Active Filter(s):
Details:
Collaboration initiates second Roche program utilizing Icagen’s ion channel drug discovery platform.
Lead Product(s): Undisclosed
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Undisclosed
Partner/Sponsor/Collaborator: F. Hoffmann-La Roche
Deal Size: $274.0 million Upfront Cash: Undisclosed
Deal Type: Collaboration May 29, 2020